Introduction
============

Abnormalities in the oral cavity of infants are not uncommon, but most are innocuous and resolve with age in the absence of treatment. Some of the most prevalent oral findings are oral inclusion cysts \[[@b1-kjp-2017-06177]\], ankyloglossia \[[@b2-kjp-2017-06177]\], vascular lesions \[[@b3-kjp-2017-06177]\], and natal teeth \[[@b4-kjp-2017-06177]\]. Other relevant conditions although less frequent are cleft lip and cleft palate, and usually a surgical treatment is needed in the first months of life \[[@b5-kjp-2017-06177]\].

Oral inclusion cysts are described as white, raised, multiple nodules of maxillary and mandibular alveolar ridges and midpalate region \[[@b6-kjp-2017-06177]\]. Fromm classified oral inclusion cysts depending on their location as Epstein pearls (midline raphe or near the junction of the hard and soft palate), Bohn's nodules (buccal and lingual areas of the dental ridges), and dental lamina cysts (located over the alveolar ridge) \[[@b7-kjp-2017-06177]\]. Most inclusion cysts of the alveolar crest and the midpalate region are apparently discharged shortly after birth. Several reports have stated a transient nature of cysts by discharge of keratin at the time of fusion of cyst walls with the oral epithelium \[[@b8-kjp-2017-06177],[@b9-kjp-2017-06177]\].

Although oral inclusion cysts in newborns have been widely described \[[@b1-kjp-2017-06177],[@b6-kjp-2017-06177]-[@b9-kjp-2017-06177]\], there are few studies evaluating possible associated factors. A previous study found that the occurrence of midpalatal and alveolar cysts differed with respect to race \[[@b10-kjp-2017-06177]\], being significantly more prevalent in white newborns compared to black newborns. On the other hand, it has been reported a direct relationship between the prevalence of palatal and alveolar cysts with increasing gestational age, increasing postnatal age, and increasing birth weight \[[@b11-kjp-2017-06177]\]. However, a recent study concluded that the frequency of palatal and gingival cysts was not significantly affected by sex, birth weight, gestational age, or delivery-pattern variables \[[@b12-kjp-2017-06177]\]. Therefore, the aim of the study was to describe the frequency of abnormalities in the newborn's oral cavity and assess its association with prenatal and perinatal factors.

Materials and methods
=====================

1. Study population
-------------------

This study included newborns within a 6-month period (December 2011 to May 2012) from the Hospital Central Ignacio Morones Prieto and the Hospital El Niño y la Mujer, both located in San Luis Potosi City (northern-central state of Mexico). The ethics committee of both hospitals and the clinical research committee of the Master's Degree in Advanced Education in General Dentistry at San Luis Potosi University approved the study. Informed parents or legal caregivers signed a written informed consent. Newborns that were breathing and had a stable health condition were included in the study. Newborns requiring intensive care were excluded.

2. Clinical examination and medical information
-----------------------------------------------

An expert in oral pathology calibrated the examiner in all variables through intraclass correlation coefficient for the reliability of the measurements. Oral findings were observed in the first 24 hours of life by visual examination. The assessment was performed using gloves, a spatula tongue depressor, and with a head flashlight. The variables examined in the oral mucosa were: location of the maxillary labial midline frenum, the symmetry of the alveolar ridges, and the presence of developmental oral inclusion cyst. Also, the presence of Fordyce's spots/granules, ankyloglossia, and natal teeth were noted. Additional information including baby's sex, birthweight, length, gestational age at delivery, Apgar scores, parity, medical disorders at birth and mode of delivery was also considered.

All the mothers were evaluated by an obstetrician during and after pregnancy, who obtained information about various maternal traits (including age, history of systemic diseases, complications during pregnancy, supplements prescribed during pregnancy, alcohol consumption, and smoking) were collected on the medical record of each patient. All women were asked about the types of vitamin supplements they used (prenatal vitamins, folic acid, iron, calcium, and other types). However, information on dosage of folic acid and multivitamin supplements was not available for all cases.

3. Statistical analysis
-----------------------

Quantitative data are expressed as a mean and standard deviation. Qualitative data are expressed as frequency and proportion. The odds ratio (OR) with 95% confidence interval (CI) were calculated using a logistic regression model to estimate the associations between Bohn's nodules, Epstein's pearls and dental lamina cysts (dependent variables) with the exposure to supplements prescribed during pregnancy (independent variables). Estimates were adjusted for mother's age, preeclampsia, urinary tract infection, gestational age and newborn's sex and weight in the analysis. For the adjustment, models were verified with Hosmer-Lemeshow tests. Data were analyzed using the IBM SPSS Statistics ver. 23.0 (IBM Co., Armonk, NY, USA). Statistical significance was set at α=0.05.

Results
=======

A total of 2,216 newborns were evaluated in the 2 hospitals. The distribution based on sex was similar, with a slightly larger number of males (53.16%). The most common oral findings were Bohn's nodules, Epstein's pearls, and dental lamina cysts ([Fig. 1](#f1-kjp-2017-06177){ref-type="fig"}). Additionally, in some cases, other intraoral findings were also observed such as odontogenic cysts, ankyloglossia, natal teeth, and vascular malformations ([Table 1](#t1-kjp-2017-06177){ref-type="table"}).

A total of 9,542 Bohn's nodules and 2,320 dental lamina cyst were observed in the examined neonates ([Table 2](#t2-kjp-2017-06177){ref-type="table"}). Bohn's nodules were more frequently located in the anterior buccal area and the posterior buccal areas of the maxilla. Similarly, dental lamina cysts were more frequent in the maxilla, with most cysts present posteriorly. Moreover, 4,520 Epstein pearls were recorded in 66% of neonates, all occurring along the midline of the hard palate. [Table 3](#t3-kjp-2017-06177){ref-type="table"} shows relevant data of the pregnant women. About fifty percent of the mothers were between 20 to 29 years old. History of systemic diseases in pregnant women was unusual; the prevalence of hypertension and diabetes mellitus was recorded about one percent. The most prevalent complications during pregnancy were infectious (bacterial urinary tract and yeast infections). The majority of women reported intake of supplements during their pregnancy, including folic acid, iron, and calcium. Alcohol and tobacco use during pregnancy was reported 1.6% and 9.9%, respectively.

In the logistic regression analyses, folic acid consumption during pregnancy raised significantly for Bohn's nodules (OR, 1.79; 95% CI, 1.23--2.55; *P*=0.002), Epstein pearls (OR, 1.63; 95% CI, 1.14--2.33; *P*=0.007), and dental lamina cysts (OR, 1.45; 95% CI, 1.02--2.05; *P*=0.038). On the other hand, preterm births were less likely to experience Bohn's nodules (OR, 0.63; 95% CI, 0.5--0.8; *P*=0.007). No significant associations were found in the use of the others traits such as calcium and iron intake, mother's age, preeclampsia, urinary tract infection, newborn's sex, and low birth weight ([Table 4](#t4-kjp-2017-06177){ref-type="table"}). [Table 5](#t5-kjp-2017-06177){ref-type="table"} shows comparisons of basic traits of newborns with or without oral inclusion cysts; there is a statistically significant difference (\<0.05) in folic acid and iron intake between groups.

Discussion
==========

In this study, 91.2% of neonates showed some anomalies in the oral cavity, being the most common finding the inclusion cystic lesions. These results are consistent with previous evidence that have shown high prevalence of oral cysts in newborns, ranging between 29% and 99% \[[@b3-kjp-2017-06177],[@b13-kjp-2017-06177],[@b14-kjp-2017-06177]\]. While most of the studies have found a higher frequency of palatal cysts compared to gingival cysts \[[@b9-kjp-2017-06177],[@b10-kjp-2017-06177],[@b14-kjp-2017-06177]\], our study presented contradictory results, with 66% of palatal cysts and 79% of gingival cysts of the population examined. The reason of this variation is not clear, but difference in race/ethnicity, sample size and methodology could be related. Several studies have shown an oral cysts racial predilection, concluding that oral cysts occur more likely in newborn of Caucasian origin compared to African-American newborns \[[@b10-kjp-2017-06177],[@b15-kjp-2017-06177]\]. All neonates included in our study consisted in Mexican mestizo race located in the north central region of the country. Thus, we were unable to make a comparison between race/ethnicity.

While previous studies have shown prevalence of ankyloglossia between 2.5% and 10.6% \[[@b3-kjp-2017-06177],[@b10-kjp-2017-06177],[@b14-kjp-2017-06177]\] with predilection in males \[[@b10-kjp-2017-06177]\], our results indicated an occurrence of 1.5% equally distributed in both male and female newborns. In agreement with similar studies around one percent or less of the population presented natal teeth \[[@b4-kjp-2017-06177],[@b16-kjp-2017-06177]\], and congenital melanocytic nevi \[[@b3-kjp-2017-06177]\].

After adjusted logistic regression multivariate analysis models, this study showed a positive association between inclusion cysts (Bohn nodules, Epstein pearls, and dental lamina cysts) and prescribed folic acid intake during pregnancy. This relationship could be limited to several factors. For instance, although all women selfreported the types of vitamins and supplements prescribed and used during pregnancy, we could not assure women adherence during periconceptional period due to the cross-sectional design of our study. Adverse effects of folic acid supplementation during pregnancy in offspring have been described, such as insulin resistance and greater adiposity \[[@b17-kjp-2017-06177]\], childhood obesity and type 2 diabetes mellitus \[[@b18-kjp-2017-06177]\], asthma \[[@b19-kjp-2017-06177]\] and worse memory scores \[[@b20-kjp-2017-06177]\]. To the best of our knowledge, no study has investigated the association between supplemented folic acid intake and oral inclusion cysts or other oral alterations in newborns.

Oral inclusion cysts have been histologically described as microkeratocysts derived from epithelial remnants of the palatal shelves and dental lamina. Epstein pearls are derived from epithelial remnants after fusion of the palatal shelves and Bohn's nodules and dental lamina cysts are remnants of degenerating dental lamina \[[@b1-kjp-2017-06177],[@b8-kjp-2017-06177],[@b21-kjp-2017-06177]\]. These epithelial remnants could proliferate, keratinize, and form small cysts \[[@b11-kjp-2017-06177]\]. Although the association of oral inclusion cysts and folic acid suggested in this study has not been previously described, a plausible biological explanation could be related to the fact that many cells can and do modify their phenotypes in response to factors that affect folate metabolism \[[@b22-kjp-2017-06177],[@b23-kjp-2017-06177]\]. Furthermore, several studies have demonstrated the importance of folic acid (alone o combined with other drugs) in the stimulation of cell growth, metabolic activity, and cell survival \[[@b23-kjp-2017-06177]-[@b25-kjp-2017-06177]\]. Also, changes in gingival cells have also been observed by the effect of folic acid, reducing cell-associated inflammatory response in human gingival fibroblasts stimulated with phenytoin and tumor necrosis factor-α \[[@b26-kjp-2017-06177]\]. Furthermore, folic acid is used combined with D-Chiro-Inositol to improve ovarian function and fertility in women affected by polycystic ovary syndrome \[[@b27-kjp-2017-06177]\]. Additionally, a significant difference was found between iron use during pregnancy with the presence of oral inclusion cysts. Evidence exists that prenatal iron intake improves birth weight \[[@b28-kjp-2017-06177]\], gestational age \[[@b29-kjp-2017-06177]\] and child intellectual development \[[@b30-kjp-2017-06177]\]. But, there have been no reports of iron use in pregnancy with oral findings in newborns.

An earlier report established a statistically significant less prevalence of palatal and alveolar cysts in premature neonates compared to full-term neonates, assuming a positive association of increased gestational age, increased postnatal age, and increased birth weight with the prevalence of cysts \[[@b11-kjp-2017-06177]\]. In our study, preterm births were negatively associated with Bohn's nodules, but no associations were found for Epstein pearls and gingiva lamina cysts. It is important to notice that all newborns were evaluated in their first 24 hours of life, unlike the oral examinations performed by Donley and Nelson \[[@b11-kjp-2017-06177]\], where the exams occurred on an average of 12 days after birth. The later evaluation could represent a possible disadvantage, because it has been demonstrated that most of the oral inclusion cysts seem to disappear within a few weeks after birth \[[@b7-kjp-2017-06177],[@b14-kjp-2017-06177]-[@b16-kjp-2017-06177],[@b31-kjp-2017-06177]\]. Moreover, it has been proposed a significant relationship between gestational diabetes, insulin treatment and cigarette consumption with the presence of oral inclusion cysts \[[@b10-kjp-2017-06177]\]. In our study, no associations between oral anomalies and maternal characteristics like age, systemic diseases, and habits (smoking, alcohol) were observed.

In conclusion, with the limitations of this study, our results suggest that folic acid could be related with the prevalence of Bohn's nodules, Epstein pearls, and dental lamina cysts in newborns. While high folic acid intake is a concern and the health implications are unclear, these anomalies do not represent a pathological concern because of its innocuous and self-limiting nature. However, further longitudinal studies are needed to explain this association.
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###### 

Prevalence of oral findings and genetic disorders in newborns

  Variable                      Female (n=1,038)   Male (n=1,178)   Total (n=2,216)
  ----------------------------- ------------------ ---------------- -----------------
  Bohn's nodules                718 (69.2)         832 (70.6)       1,550 (70.0)
  Epstein's pearls              676 (65.1)         787 (66.8)       1,463 (66.0)
  Dental lamina cysts           461 (44.4)         530 (45.0)       991 (44.7)
  Odontogenic cysts             32 (3.1)           24 (2.03)        56 (2.5)
  Ankyloglossia                 16 (1.5)           17 (1.4)         33 (1.5)
  Natal teeth                   4 (0.4)            5 (0.4)          9 (0.4)
  Vascular malformation         2 (0.2)            4 (0.3)          6 (0.3)
  Congenital melanocytic nevi   1 (0.1)            0 (0)            1 (0.1)
  Lipoma                        1 (0.1)            2 (0.2)          3 (0.1)
  Cleft lip                     1 (0.1)            0 (0)            1 (0.1)
  Cleft palate                  1 (0.1)            0 (0)            1 (0.1)

Values are presented as number (%).

###### 

Distribution of Bohn's nodules and dental lamina cysts by location and sex

  Variable                        Female         Male           Total
  ------------------------------- -------------- -------------- --------------
  Bohn's nodules (n=9,542)                                      
   Buccal anterior                1,530 (43.5)   2,092 (45.9)   3,622 (44.8)
   Buccal posterior               1,920 (54.6)   2,316 (50.8)   4,236 (52.4)
   Palatal anterior               66 (1.9)       147 (3.2)      213 (2.6)
   Palatal posterior              0 (0)          7 (0.2)        7 (0.1)
   Total                          3,516 (100)    4,562 (100)    8,078 (100)
  Mandible                                                      
   Buccal anterior                131 (20.4)     90 (10.9)      180 (12.3)
   Buccal posterior               318 (49.6)     416 (50.5)     734 (50.1)
   Lingual anterior               90 (14.0)      174 (21.1)     305 (20.8)
   Lingual posterior              102 (15.9)     143 (17.4)     245 (16.8)
   Total                          641 (100)      823 (100)      1,464 (100)
  Dental lamina cysts (n=2,320)                                 
   Maxilla                                                      
    Anterior                      134 (15.2)     177 (14.3)     311 (14.7)
    Posterior                     750 (84.8)     1,061 (85.7)   1,811 (85.3)
    Total                         884 (100)      1,238 (100)    2,122 (100)
   Mandible                                                     
    Anterior                      74 (80.4)      93 (87.7)      167 (84.3)
    Posterior                     18 (19.6)      13 (12.3)      31 (15.7)
    Total                         92 (100)       106 (100)      198 (100)

Values are presented as number (%).

###### 

Maternal prenatal medical data (n=2,168)

  Variable                                   Number (%)
  ------------------------------------------ --------------
  Age (yr)                                   
   14--19                                    631 (29.1)
   20--29                                    1,093 (50.4)
   30--39                                    405 (18.7)
   \>40                                      39 (1.8)
  Systemic disease                           
   Diabetes mellitus                         22 (1.01)
   Hypertension                              27 (1.3)
   Hypothyroidism                            7 (0.3)
   Epilepsy                                  6 (0.3)
   Asthma                                    5 (0.2)
  Disease occurred during pregnancy          
   Urinary tract infection                   1,045 (48.2)
   Yeast infection                           102 (4.7)
   Preeclampsia                              49 (2.3)
   Gestational diabetes mellitus             26 (1.2)
  Supplements prescribed during pregnancy.   
   Folic acid                                1,629 (75.1)
   Iron                                      1,478 (68.2)
   Calcium                                   55 (2.5)

###### 

Adjusted OR and 95% CI for the association between oral inclusion cysts in newborns and supplements prescribed during pregnancy

  Variable                                                           Bohn's nodules      Epstein's pearls                                            Dental lamina cysts                                                                                
  ------------------------------------------------------------------ ------------------- ----------------------------------------------------------- --------------------- -------------------------------------------------------- ------------------- --------------------------------------------------------
  Folic acid use                                                     1.79 (1.23--2.55)   0.002^[\*](#tfn1-kjp-2017-06177){ref-type="table-fn"}^      1.63 (1.14--2.33)     0.007^[\*](#tfn1-kjp-2017-06177){ref-type="table-fn"}^   1.45 (1.02--2.05)   0.038^[\*](#tfn1-kjp-2017-06177){ref-type="table-fn"}^
  Calcium use                                                        1.31 (0.72--2.37)   0.381                                                       0.83 (0.49--1.41)     0.501                                                    0.85 (0.51--1.43)   0.553
  Iron use                                                           1.05 (0.75--1.47)   0.799                                                       1.04 (0.76--1.44)     0.794                                                    0.92 (0.67--1.25)   0.582
  Mother's age \<20 yr                                               0.90 (0.72--1.11)   0.317                                                       0.98 (0.80--1.20)     0.878                                                    1.02 (0.84--1.25)   0.815
  Mother's age ≥40 yr                                                0.79 (0.43--1.45)   0.434                                                       1.02 (0.56--1.89)     0.926                                                    0.48 (0.24--0.93)   0.129
  Preeclampsia                                                       0.86 (0.50--1.46)   0.561                                                       0.69 (0.40--1.16)     0.158                                                    0.71 (0.41--1.22)   0.216
  Urinary tract infection                                            0.51 (0.20--1.29)   0.153                                                       1.57 (0.55--4.44)     0.397                                                    0.88 (0.68--1.17)   0.245
  Newborn's male sex                                                 1.19 (0.99--1.42)   0.063                                                       1.22 (1.03--1.46)     0.055                                                    1.12 (0.95--1.33)   0.188
  Preterm birth^[†](#tfn2-kjp-2017-06177){ref-type="table-fn"}^      0.63 (0.50--0.80)   \<0.0001^[\*](#tfn1-kjp-2017-06177){ref-type="table-fn"}^   1.06 (0.83--1.35)     0.658                                                    0.86 (0.68--1.10)   0.225
  Posterm birth^[‡](#tfn3-kjp-2017-06177){ref-type="table-fn"}^      0.63 (0.10--3.80)   0.609                                                       2.35 (0.26--8.3)      0.448                                                    1.87 (0.31--11.2)   0.498
  Low birth weight^[§](#tfn4-kjp-2017-06177){ref-type="table-fn"}^   0.97 (0.79--1.36)   0.857                                                       1.38 (0.94--1.88)     0.129                                                    0.82 (0.59--1.14)   0.238

OR, odds ratio; CI, confidence interval.

P\<0.05, statistically significant.

\<37 weeks of pregnancy.

42 Weeks of pregnancy.

Birth weight less than 2,500 g.

###### 

Comparison of traits in newborns with and without oral inclusion cysts (OICs)

  Variable               Presence of OIC (n=2,021)   No presence of OIC (n=195)   *P* value^[\*](#tfn5-kjp-2017-06177){ref-type="table-fn"}^                
  ---------------------- --------------------------- ---------------------------- ------------------------------------------------------------ ------------ ---------
  Male newborns          1,077 (53.3)                \-                           101 (51.8)                                                   \-           0.806
  Female newborns        944 (46.7)                  \-                           94 (48.2)                                                    \-           
  Folic acid             1,524 (75.4)                \-                           105 (53.8)                                                   \-           \<0.001
  Iron                   1,369 (67.7)                \-                           109 (55.9)                                                   \-           \<0.001
  Calcium                52 (2.57)                   \-                           3 (1.54)                                                     \-           0.368
  Mother's age (yr)      \-                          24.2±6.44                    \-                                                           24.5±6.54    0.574
  Gestational age (yr)   \-                          38.9±0.150                   \-                                                           38.6±0.125   0.518
  Birth weight (g)       \-                          3099.9±455                   \-                                                           3,072±473    0.639
  Birth length (cm)      \-                          49.8±2.29                    \-                                                           50.1±2.03    0.273

SD, standard deviation.

Chi-square test for qualitative variables and Mann Whitney *U* test for quantitative variables.
